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Background and aim: Appropriate and timely initial fluid resuscitation in acute pancreatitis (AP) is
critical. The aim of this retrospective study was to evaluate fluid therapy on an hour-by-hour basis in
relation to standard indices of adequate resuscitation during AP.
Methods: Emergency room shock charts, fluid balance sheets and intensive care (ICU) charts for all
patients with AP admitted to ICU in a large acute hospital were examined. Vital signs, clinical course and
fluid administered during the first 72 h after admission were tabulated against urine output, central venous
pressure (CVP) and inotrope/vasopressor therapy.
Results: Sixty-three consecutive patients with AP were initially evaluated. Inter-hospital transfers with
established organ dysfunction (n = 11) or where records had insufficient detail (n = 22) were excluded. In
the remaining 30 patients, in-hospital death occurred in 7. The cumulative volume of crystalloid given was
significantly less at 48 h in patients who died in hospital (3331  800 ml vs. survivors, 7287  544 ml;
P < 0.001). Non-survivors had a higher CVP, and received more inotropes/vasopressors.
Conclusion: In severe AP-associated organ failure, fluid resuscitation profiles differ between survivors
and non-survivors. CVP alone as a crude indicator of adequate resuscitation may be unreliable, poten-
tially leading to the use of inotropes/vasopressors in the inadequately filled patient.
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Introduction
Severe acute pancreatitis (AP) is a catastrophic inflammatory dis-
order of the pancreas which causes significant morbidity and
mortality worldwide. The natural history of AP varies from a
relatively mild, self-resolving illness to a severe clinical course
characterized by multiple organ failure in approximately 20% of
patients.1 Despite increased recognition of the importance of
critical care and the increased availability of level 2 and level 3
critical care resources, overall mortality rates remains high (and
unchanged) at approximately 7.5–9%2 with mortality rates of
20–25% in patients with severe disease.3 The key determinant of
mortality is the development and persistence of multiple organ
failure.4 It is now recognized that this is an event early in the
disease course. The modal pattern of organ dysfunction is acute
lung injury, followed by renal injury, usually in a cumulative
manner.5 At present, there is no specific therapy for AP and the
mainstays of management are largely supportive.6
Fluid resuscitation is integral to the acute management of
patients with AP but there is limited evidence to inform a specific
fluid resuscitation regimen with regard to the optimum rate,
volume and fluid type.7,8 Gardner et al. have recently reported that
patients who receive timely early fluid therapy in acute pancreati-
tis (more than 33% of the first 72 h total volume delivered in the
first 24 h) have lower mortality.9 This supports other studies of
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fluid resuscitation and nutrition in patients with severe AP which
have found a significant association between hypovolaemia at
presentation and increased mortality.10 Conversely, in a random-
ized study of patients with acute lung injury (arising mainly from
pneumonia, sepsis, aspiration, trauma and multiple transfusions),
a conservative fluid resuscitation regime was associated with
improved lung function and increased ventilator-free days
(although no change in 60-day mortality) when compared with a
liberal fluid regime.11
In addition to uncertainty regarding fluid type, rate and
volume, there are several non-invasive and invasive tools available
to guide resuscitation end-points. Whereas a goal-directed
approach to resuscitation is likely to be useful in many critically ill
patients, as evidenced by Rivers et al.,12 this has not yet been
shown in AP, although there are two randomized controlled
studies of early goal-directed fluid resuscitation in patients with
AP in progress.13,14 There is evidence that pulmonary artery
catheter-guided resuscitation does not lead to improved survival
or organ function compared with central venous catheter-guided
therapy (and is associated with more frequent and more serious
complications in acute lung injury).15 In everyday practice, central
venous pressure (CVP) is frequently used as a surrogate marker of
adequate volume resuscitation albeit with increased recognition
of its limitations.16 Conceptually, the most severe biochemical and
metabolic derangements in AP occur in the intracellular compart-
ment; this compartment should therefore be the logical target for
therapy. However, the compartment that is routinely accessed for
fluid administration and from which surrogates of adequacy of
resuscitation are monitored (for example CVP), is the intravascu-
lar space. This generates a logical disconnect between the com-
partment being monitored and the target compartment for
resuscitation therapy.
Given the likely benefit of optimizing initial fluid resuscitation in
AP, the aim of the present study was to define the existing standard
of care specific to fluid therapy on an hour-by-hour basis, in
relation to standard indices of adequate resuscitation. Therefore, a
retrospective analysis of current practices within the first 72 h after
hospital admission in patients with AP who required admission to
the intensive care unit (ICU) was performed.
Methods
Ethics
Exemption from a full Regional Health Ethics of Research Com-
mittee application was advised after internal assessment by the
College of Medicine Office of the University of Edinburgh, as the
present study was formally classified as a clinical audit. In addi-
tion, all data were fully anonymized at the time of collection, and
therefore individual informed consent was not required. Caldicott
guardian approval was given.
Patients
The Royal Infirmary of Edinburgh ICU Ward Watcher database
(Ward Watcher® Critical Care Systems, Yorkshire, UK) was
searched to identify consecutive patients admitted to the ICUwith
a diagnosis of AP (ICD-10: K85) from 1st July 2004 to 1st January
2008. AP was diagnosed in the presence of abdominal pain with
elevated serum amylase >3 times the upper limit of the reference
range or CT scan evidence of AP. Patients admitted to the ICU as
inter-hospital transfers with established AP-associated organ dys-
function were excluded from the analysis due to the requirement
for an uninterrupted data stream of 72 h duration from the time
of presentation to the emergency department.
Data collection
Patient demographics, Acute Physiology and Chronic Health
Evaluation (APACHE-II) score (worst values in the first 24 h),
timing and duration of ICU admission, length of inpatient stay
and mortality were recorded. Individual hospital records were
reviewed regarding aetiology of AP and vital observations at pre-
sentation to hospital. Vasopressor, fluid administration and urine
output during the first 72 h after hospital admission were trans-
posed (at a data resolution of 1 h) from the emergency depart-
ment shock charts, ward fluid balance sheets and the ICU
observation charts into an electronic format. The hourly amount
and type of fluid administered were recorded, including the fol-
lowing crystalloid preparations: 0.9% saline, 5% dextrose, 10%
dextrose and 50% dextrose, Hartmann’s solution, 1.26% sodium
bicarbonate, phosphate; colloid preparations: Gelofusine, 4.5%
human albumin solution; and blood products.
Data analyses
Continuous variables which conformed to the normal distribu-
tion by 1-sample Kolmogorov–Smirnov test are described using
the mean and standard error. Those where the data were not
normally distributed are described as median and interquartile
range. Categorical variables, for example, gender and aetiology of
AP are given as absolute numbers and proportions (%). The
hourly volume of vasopressor administered was corrected for con-
centration to an equivalent volume of 6% Noradrenaline. Depen-
dent variables over time from admission (fluid and vasopressor
administration and vital observations) were compared between
patients categorized by hospital outcome. Volume of crystalloid
administered at 12, 24, 48 and 72 h was compared between the
patient categories using one-way anova and the Student-
Neuman-Keuls post-hoc test. Time to critical care admission was
compared between hospital outcome groups using Kaplan–Meier
analysis using the log rank test. Data analysis was performed using
SPSS (SPSS 15.0 forWindows; SPSS; Chicago, IL, USA). Statistical
significance was assumed if P < 0.050.
Results
The flow chart for patient inclusion is presented as Fig. 1. Sixty-
three patients with severe AP were identified from the ICU Ward
Watcher database and considered for inclusion. Eleven patients
were excluded as they were admitted after transfer from other
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hospitals and a further 22 patients were excluded as examination
of their hospital records revealed discontinuities in the data
stream for one or more key variables. Thus, a total of 30 patients
(15 male, 15 female) had complete records and underwent
detailed scrutiny in this study.
Baseline characteristics
The mean age of the patients was 56.4 (2.7) years with a mean
APACHE-II score of 18.3 (1.6). The aetiology of AP was gall-
stones in 12, alcohol in 8, drugs in 1 and unknown in 9 patients.
Age and APACHE-II scores did not differ significantly between
patients with AP of gallstone, alcohol or unknown aetiology (one-
way anova, P = 0.447 and P = 0.771, respectively).
Hospital mortality for the cohort was 7 out of 30. Deaths
occurred at 26 h, 41 h, 51 h, 77 h, 6 days, 30 days and 76 days from
the time of presentation to hospital. The overall average length of
ICU and hospital stay was 3.2 (1.2, 17.1) and 47.5 (10.8) days,
respectively. Table 1 shows the comparison between survivors and
non-survivors for age, time to critical care (HDU/ICU) admis-
sion, APACHE-II score (worst values in first 24 h), Glasgow score
(worst values in first 48 h) and peak C-reactive protein (CRP)
(first 48 h). In summary, there were no significant differences
between survivors and non-survivors for these variables.
Baseline characteristics of those patients excluded as inter-
hospital transfers, or because hospital records were incomplete
were not remarkably different from those included; data relating
to these patients are included as supplementary Tables S1 and S2,
respectively.
Fluid administration
Figure 2a displays the cumulative volume of crystalloid fluids
administered to patients grouped by hospital outcome. Interest-
ingly, the cumulative crystalloid volumes appear equal until
approximately 6 h after admission, whereupon the cumulative
crystalloid volume curves diverge, with less volume given to
patients who subsequently died. This became significant at 48-h
post-admission (one-way anova, P < 0.001). However, patients
who died appeared to receive a greater volume of cumulative
colloid within the second 24 h after admission (Fig. 2b). The
cumulative volume curves were similar between hospital outcome
groups during the first 2 days post-admission, but appeared to be
lower during the third day among patients who died (Fig. 2c),
although the difference was not statistically significant.
Vital observations
Hourly respiratory rates (RR) were similar between patients
grouped by hospital outcome (data not shown). Median CVP was
higher in patients who died [18 mmHg (15, 19)] compared with
those who survived [11 mmHg (7, 14)] (P < 0.001, Mann–
Whitney U-test) (Fig. 3a). Despite this seemingly adequate
preload, median urine output was lower in non-survivors [1 ml/h
(0, 20)] compared with survivors [35 ml/h (10, 60)] (P < 0.001,
Mann–Whitney U-test) (Fig. 3b).
Ventilatory support
Continuous positive airway pressure (CPAP) ventilation was
used in one non-survivor, and in 9 out of 23 survivors (Fisher’s
exact test, 1 d.f., P = 0.302). The median CVP was 13 mmHg (8,
16) in those who did not receive CPAP, and 12 mmHg (7, 15) in
those who did (P = 0.015, Mann–Whitney U-test). The details
regarding endotracheal intubation and mechanical ventilation
for the cohort are presented in Table 2. Importantly, endotra-
cheal intubation and mechanical ventilation did not result in a
significantly higher CVP (Fig. 3c, Mann–Whitney U-test, P =
0.741) in the cohort as a whole. When CVP was compared
between survivors and non-survivors while they were intubated
(Fig. 3d) or while they were not (Fig. 3e), the median CVP
remained significantly higher in non-survivors (Table 2). Thus,
endotracheal intubation and mechanical ventilation was not a
confounding factor for the elevated CVP observed in non-
survivors.
Vasopressors
Figure 4 shows the hourly equivalent volume of 6% Noradrena-
line given, which was significantly higher in non-survivors
[44 ml/h (29, 86)] compared with survivors [12 ml/h (8, 18)]
(P < 0.001 Mann-Whitney U-test).
Discussion
In the present study, the intravenous fluid resuscitation profiles of
patients with severe AP admitted to critical care are reported, and
analysed in relation to standard indices of fluid repletion (CVP
and urine output), and to the amount of vasopressor used.When
the data streams were compared between survivors and non-
survivors, the most salient findings were that non-survivors:
Diagnosis AP, ICU 
database 1/7/04 to 1/1/08
n=63 
Direct admissions 
n=52 
Patients studied in detail 
n=30 
Interhospital transfers 
excluded 
n=11 
Incomplete hospital 
records 
n=22 
Figure 1 Study flowchart
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(i) received significantly less fluid than survivors, particularly
crystalloids; (ii) had consistently higher CVP; and (iii) were given
significantly greater amounts of vasopressors as adjuncts to fluid
resuscitation.
This study included detailed resolution data, with information
recorded on an hour-by-hour basis. This facilitated a detailed
examination of the comparative rates of crystalloid, colloid and
vasopressor administration and the corresponding CVP mea-
surements. In particular, the level of detail permitted the evalu-
ation of how these variables changed at critical points during the
very earliest phases of resuscitation. By selecting death from AP
as a hard, unequivocal endpoint to be the group comparator, one
source of potential bias has been minimized by avoiding the use
of surrogate markers of adequacy of resuscitation. Furthermore,
by rigorously setting the start time as the moment the patient
presented to the emergency department, i.e. the earliest point at
which intravenous fluid resuscitation could realistically com-
mence, and by researching the source data for that interval prior
to admission to level 2 or 3 critical care, this study has practical
relevance with regard to early fluid resuscitation. The present
study specifically required the source data to be absolutely com-
plete for 72 h from presentation, and excluded those patients for
whom records were not entirely complete. Although this may be
regarded as a positive attribute of this study, in that the rigorous
exclusion of incomplete data should increase accuracy, it also
resulted in the exclusion of 22 from 52 patients. Because all
patients (survivors and non-survivors) in the present study
received greater than one-third of the 72-h total fluid in the first
24 h, it was not possible to explore whether the data in this study
corroborated the finding of Gardner et al.,9 that ‘front-loading’
fluid resuscitation to the first 24 h after presentation may be
associated with improved survival. This may reflect differences
in emergency care pathways between centres.
Being a retrospective study, this paper relies on the accuracy of
observations recorded on the various emergency department
observation charts, ward charts and ICU charts, and is insensi-
tive to any discrepancy between the amount of fluid recorded as
being given and that actually entering the patient. While there is
no reason to believe that any discrepancy exists, it is acknowl-
edged that in the emergency setting when patients are moving
from the emergency department to the ward and then to a criti-
cal care environment, there is potential for an error of recording.
The size of the cohort also affects the sensitivity to confounding.
With a limited sample size, any individual patient variation
including that unrelated to AP might result in undetected con-
founding. For example, a patient presenting with drug-related
AP as a result of statin therapy for a previous myocardial inf-
arction might have an elevated CVP because of pre-existing
cardiac failure rather than due to any AP-associated disease
process. Although no such instances were identified in this study,
Table 1 Demographics and disease severity
Survivors Non-survivors Significance
(P-value)
Time to critical care (hours) 17 (6, 35) 13 (4, 52) 0.88†
Age (years) 53 (43, 61) 68 (50, 73) 0.25*
APACHE-II (worst values in first 24 h) 19 (13, 21) 18 (16, 29) 0.25*
Glasgow score (worst values in first 48 h) 5 (4, 6) 6 (4, 7) 0.57*
Peak CRP (first 48 h) 231 (12, 233) 95 (65, 411) 0.67*
*Mann–Whitney U-test.
†Log-rank test.
Values are median (25th, 75th centile).
CRP, C-reactive protein.
Table 2 Details of endotracheal intubation and mechanical ventilation
Survivors Non-survivors Significance
(P-value)
Number of patients requiring endotracheal tube and ventilation during admission 15 of 23 7 of 7 0.084†
Number of patients requiring endotracheal tube and ventilation during the first 72 h 11 of 23 6 of 7 0.089†
Ventilation started (days after presentation) 1 (0, 3) 1 (0, 2.5) 0.89*
Duration of ventilated period (days) 4 (0, 19) 2 (1, 3) 0.96*
CVP while ventilated (mmHg) 10 (6, 14) 18 (16, 20) <0.001*
CVP while not ventilated (mmHg) 12 (8, 15) 17 (14, 19) <0.001*
*Mann–Whitney U-test.
†Fisher's exact test.
Values are median (25th, 75th centile).
CVP, central venous pressure.
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the magnitude of the effect of such confounding variables would
be reduced with a larger sample size.
The main message of the present study is that in severe AP a
normal or raised CVP does not necessarily mean that the patient
is sufficiently fluid replete. This supports the systematic analysis of
Marik et al. which evaluated the relationship between CVP and
changes in CVP with cardiac index.16 In that report, the authors
found that CVP poorly reflected blood volume, and did not
predict the response to a fluid challenge. Hypothetically,
AP-associated acute lung injury may cause pulmonary hyperten-
sion and the systemic inflammation in AP may result in myocar-
dial dysfunction. Both of these examples, among several others,
could result in elevated CVP readings in the under-filled patient.
It is therefore important not to rely exclusively on CVP as an
indicator of sufficient fluid repletion prior to the administration
of vasopressors. Whether the findings could be simply explained
by the premise that those patients who did not survive were sicker
to begin with, and would therefore have had greater requirements
for vasopressor support was considered. Several facts dissuade
from this point of view. First, if the non-survivors were simply
sicker to begin with, it might be expected that at least an equal, if
not a greater amount of fluid would be given to those more
critically ill. In the present study, the converse was observed.
Second, robust and accepted prognostic scores, namely the worst
APACHE-II score in the first 24 h, the highest Glasgow score and
peak CRP in the first 48 h were not different between survivors
and non-survivors, suggesting that the groups were equally sick.
Third, the interval between presentation and critical care was
similar, implying that those patients needing critical care were
identified with equal speed, and transferred with equal urgency.
The risk–benefit profile of vasopressors in multiple organ
failure is extremely complex and the pathophysiological responses
during AP-associated organ failure are incompletely under-
stood.17,18 Despite these challenges, most doctors take the prag-
matic approach of combining fluid resuscitation with vasopressor
use, using surrogate markers of adequacy of resuscitation, for
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example CVP, to direct when fluid administration should be
reduced and vasopressor administration increased. If, however,
the CVP is misinterpreted as indicating adequate filling (and
therefore preload) when in reality the patient is still fluid deficient,
vasopressors risk being given at increasing doses inappropriately,
with a potentially deleterious effect on the outcome. This is com-
pounded further by the compartmentalized nature of fluid redis-
tribution and its disruption during severe AP.
In the ideal situation, albeit somewhat simplified, the intravas-
cular space is replenished and there is redistribution throughout
the compartments; a sustained elevation in CVP informs
adequacy of resuscitation, fluid administration is slowed and
adjunctive vasopressors are administered. However, if redistribu-
tion between compartments is not physiological, as is likely to be
the case, as a result of the derangement in endothelial function,19
cellular energy balance20 and energy-dependent and passive mem-
brane transport systems, it is possible that the CVPmight indicate
intravascular repletion when the intracellular compartment
remains significantly under-resuscitated. The disconnect between
the site of maximum derangement (the intracellular space) and
the access point for fluid administration and measurement of
CVP (the intravascular compartment) leads to our preferred
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explanation for the data presented in this study. Furthermore, it
could be speculated that, as AP is associated with both myocardial
dysfunction and acute pulmonary injury, either or both entities
may cause elevated right heart pressures and hence a misleading
CVP with respect to adequate preload.
In practical terms, adopting a more liberal approach to early
fluid resuscitation, with the judicious use of vasopressors, and not
relying on an isolated CVP reading to indicate adequate fluid
administration is recommended. While this study is not designed
to generate a specific fluid administration guideline, and the
design or data certainly do not permit this study to be prescriptive
in this regard, it is noted that survivors in this study on average
received approximately 6 litres of volume resuscitation in the first
24 h, 4 litres in the second 24 h and 2.5 in the third 24 h. It is
essential to qualify this observation by reiterating that the correct
approach will not be a simple ‘one volume for all-comers’ but will
need a careful individualized fluid prescription based on the
patient, their specific physiological derangement and a more
sophisticated approach to measuring and monitoring response.
In conclusion, the present study supports the notion that CVP
alone may not be a good predictor of adequate fluid resuscitation
in acute pancreatitis.A disconnect between the target of our resus-
citation (the intracellular space) and the compartment that is
easily monitored (the intravascular space) is potentially problem-
atic. Although newer methods of monitoring show great promise,
for example cardiac output monitoring using thermal or lithium
dilution techniques based on the Fick principle, or trans-
esophageal Doppler waveform analysis, these methods may not
necessarily resolve the disconnect because they, like the CVP, focus
on the intravascular compartment. However, these modalities
may offer a more accurate indicator of adequate preload through
more complicated mathematical algorithms than simply hydro-
static pressure, and certain methods are receiving deserved atten-
tion in prospective studies.13,14 Alternative end-points of adequate
resuscitation, for example based on oxygen delivery, are also under
investigation and may prove to be valuable alternatives. It will be
interesting to see whether these improved methods of judging
adequate filling might be practically applied to a general patient
population with AP and, most importantly, whether they lead to a
significant improvement in outcome.
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